Ovarian cancer stage 3

Clinical trials for Ovarian cancer stage 3 explained in plain language.

Never miss a new study

Get alerted when new Ovarian cancer stage 3 trials appear

Sign up with your email to follow new studies for Ovarian cancer stage 3, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1

New vaccine combo aims to outsmart ovarian cancer resistance

Disease control Not yet recruiting

This phase 2 trial tests whether a peptide vaccine (NY-ESO-1) combined with an immunotherapy drug (toripalimab-tpzi) can prevent resistance to treatment in 24 women with stage III/IV ovarian cancer that no longer responds to platinum chemotherapy. The vaccine primes the immune sy…

Matched conditions: OVARIAN CANCER STAGE 3

Phase 2 • Sponsor: Georgetown University • Aim: Disease control

Last updated Jun 27, 2026 11:02 UTC

Ovarian cancer stage 3

Get alerted when new Ovarian cancer stage 3 trials appear

New vaccine combo aims to outsmart ovarian cancer resistance